NSMS National Clinical Laboratory Network (aLab)

Led by Lewis Nelson, MD

Advancing Pathology, Clinical Chemistry, and Diagnostics Through Autonomous Science, AI, and Mechanistic Medicine

The NSMS National Clinical Laboratory Network (aLab) is a next-generation centralized hospital diagnostic and translational hub integrating autonomous experimentation, mechanistic systems biology, AI-enabled inference, and real-world clinical pathology and laboratory medicine to understand, predict, and mitigate complex human diseases and acute toxic exposures.

Led by internationally recognized physician and clinical systems architect Lewis Nelson, MD, the network combines computational pathology, deep molecular profiling, automated digital twin modeling, autonomous robotics, and causal inference systems to transform the hospital laboratory from a reactive testing department into a predictive, mechanistically explainable engine of precision medicine.

The network focuses on automating and deeply analyzing how disease processes, systemic infections, metabolic shifts, environmental toxins, and pharmaceuticals interact with molecular, cellular, organ, and whole-body human physiology across the complete hospital ecosystem.

Mission

To establish an autonomous, continuously learning clinical laboratory and pathology ecosystem capable of predicting, simulating, validating, and optimizing human diagnostic and therapeutic trajectories across biologic scales.

Core Scientific Programs

Autonomous Hospital Laboratory Systems

Development of closed-loop clinical diagnostic architectures integrating:

  • AI-guided experimental design and autonomous specimen routing

  • Autonomous robotics for high-throughput specimen handling (DrRobots™)

  • Real-time physiologic sensing and electronic health record (EHR) integration

  • Mechanistic digital twins for real-time patient risk forecasting

  • Organ-on-chip and microfluidic microphysiological validation systems

  • Multiscale molecular profiling across whole-blood and tissue biopsy samples

  • Continuous causal inference for rapid differential diagnostics

Advanced Pathology & Tissue Morphologics

The laboratory network modernizes anatomical and digital pathology by investigating:

  • Spatial omics and automated tissue microdissection

  • Deep phenotypic classification of oncology and inflammatory biopsies

  • Cellular trafficking mechanisms and barrier transport dynamics

  • Real-time intraoperative margin analysis via machine perception

  • Neuro-pathologic and systemic immune-system dysregulation profiles

Platforms include:

  • Automated high-resolution digital slide scanning and semantic segmentation

  • Spatial transcriptomics paired with multiplexed tissue imaging

  • Single-cell transcriptomic arrays of hematologic and liquid biopsy samples

  • Autonomous primary tissue culture and screening environments

Clinical Chemistry, Toxicology & Precision Medicine

Core inpatient laboratory programs focus on:

  • Automated clinical chemistry panels and metabolic flux tracking

  • Personalized antidote and drug dose optimization loops

  • Real-time ICU laboratory monitoring and automated critical-value alerts

  • Real-time physiologic pharmacokinetic and pharmacodynamic modeling

  • Predictive acute organ failure and clinical overdose analytics

  • AI-guided clinical intervention modeling

Systems integrate patient-specific digital twins capable of forecasting metabolic and toxic trajectories before irreversible physiological injury develops.

Core Technologies

  • aMks™: 1,966-marker high-dimensional molecular profiling array

  • aEyes™: Multiscale automated imaging, digital pathology, and physiologic perception

  • aTwins™: Mechanistic patient-specific digital twin modeling architecture

  • aLab™: next-generation AI-enabled autonomous laboratory integrating clinical diagnostics, translational research, and mechanistic disease modeling.

  • aArmour™: High-throughput microfluidic organ-on-chip validation platforms

  • DrRobots™: Autonomous wet-lab experimentation and robotic sample intervention workcells

R&D Areas

  • Anatomical and Clinical Pathology

  • Inpatient Clinical Chemistry & Hematology

  • Medical and Computational Toxicology

  • Precision Diagnostics & Predictive Medicine

  • Inpatient Critical Care (ICU) Lab Automation

  • Pharmacokinetics & Pharmacodynamics (PK/PD)

  • Autonomous Experimental Workflows

  • Mechanistic Systems Biology

  • AI-Driven Target and Biomarker Identification

Leadership

Lewis Nelson, MD

Director, NSMS National Clinical Laboratory Network (aLab) Lewis S. Nelson, MD, is an internationally recognized leader in clinical diagnostic systems, pharmacology, toxicologic systems biology, and translational medicine. His career focuses on integrating mechanistic diagnostics, computational biology, and AI-enabled healthcare networks to advance precision medicine, modern hospital pathology, and autonomous clinical intelligence.

The Near Future of Laboratory Medicine

The NSMS National Clinical Laboratory Network (aLab) is building the future of autonomous diagnostics—a continuously adaptive intelligence infrastructure capable of understanding, predicting, and optimizing human responses across molecular, cellular, tissue, organ, and whole-body scales directly within the modern hospital care continuum.